Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology. [PDF]
Dermatol Ther (Heidelb)Augustin M, Hong HC, Torres T, Issa NT.
europepmc +1 more source
Older Patients with Atopic Dermatitis Show More Pronounced Early Clinical Improvement with Tralokinumab: A Single-Center Retrospective Real-World Study. [PDF]
J Clin MedSato E +4 more
europepmc +1 more source
Tralokinumab in atopic dermatitis
Forum DermatologicumAnna Czaplicka, Irena Walecka
openaire +1 more source
Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety. [PDF]
Curr Ther Res Clin ExpMasoumi N +5 more
europepmc +1 more source
Biomarkers in atopic dermatitis: Current evidence and unmet needs. [PDF]
J Eur Acad Dermatol VenereolSalman A, Kocatürk E.
europepmc +1 more source
Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]
Clin Cosmet Investig DermatolAvriyanti E +6 more
europepmc +1 more source
State-of-the-Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review. [PDF]
Pediatr DermatolElaiho CR +4 more
europepmc +1 more source
Rapid and long-lasting remission of refractory Hailey-Hailey disease by IL-13 inhibition with tralokinumab. [PDF]
J Dtsch Dermatol GesBrandt O, Huber SM, Mueller SM.
europepmc +1 more source
Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study. [PDF]
J DermatolCascio Ingurgio R +6 more
europepmc +1 more source
Biologic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Bayesian Network Meta-Analysis of Established and Investigational Agents. [PDF]
CureusBabul A +4 more
europepmc +1 more source